Influence of angiotensinogen and angiotensin-converting enzyme polymorphisms on cardiac hypertrophy and improvement on maximal aerobic capacity caused by exercise training

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 16, Issue 4, 2009, Pages 487-492

  Alves, Guilherme B ^a   Oliveira, Edilamar M ^a   Alves, Cleber R ^a   Rached, Heron R S ^a   Mota, Glória F A ^a   Pereira, Alexandre C ^a   Rondon, Maria U ^a   Hashimoto, Nara Y ^a   Azevedo, Luciene F ^a   Krieger, José Eduardo ^a   Negrão, Carlos Eduardo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiac hypertrophy; Exercise training; Genetic; Peak oxygen consumption

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; METHIONINE;

ADULT; AEROBIC CAPACITY; ALLELE; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CLINICAL EVALUATION; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; EXERCISE; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PHYSICAL ACTIVITY; POLICE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 70349207554     PISSN: 17418267     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32832c5a8a     Document Type: Article

References (33)

1. Brewster UC, Skidgel RA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 2004; 116:263-272.
2. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 1991; 9:3-15.
3. Touyz RM. Activated oxygen metabolites: do they really play a role in angiotensin II-regulated vascular tone? J Hypertens 2003; 21:2235-2238.
4. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for the variance of serum enzyme levels. J Clin Invest 1990; 86 :1343-1346.
5. Myerson SG, Hemingway H, Budget R, Martin J, Humphries S, Montgomery H. Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 1999; 87:1313-1316.
6. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51:197-205.
7. Danser AHJ, Schalekamp MADH, Bax WA, Maassen van den Brink A, Saxena PR, Riegger GAJ, et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 92 :1387-1388.
8. Fatini C, Guazzelli R, Manetti P, Battaglini B, Gensini F, Vono R, et al. RAS genes influence exercise-induced left ventricular hypertrophy: an elite athletes study. Med Sci Sports Exerc 2000; 32:1868-1872.
9. Hernandéz D, de La Rosa A, Barragan A, Barrios Y, Salido E, Torres A, et al. The ACE/DD genotype is associated with the extent of exercise in endurance athletes. J Am Coll Cardiol 2003; 42:527-532.
10. Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi MA, Hemingway H, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997; 96:741-747.
11. Montgomery HE, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C, et al. Human gene for physical performance. Nature 1998; 393:221-222.
12. Rankinen T, Pérusse L, Borecki I, Gagnon J, Chagnon YC, Leon AS, et al. Angiotensin-converting enzyme ID polymorphism and fitness phenotype in the HERITAGE family study. J Appl Physiol 2000; 88 :1029-1035.
13. Sonna LA, Sharp MA, Knapik JJ, Cullivan M, Angel KC, Patton JF, et al. Angiotensin-converting enzyme genotype and physical performance during US army basic training. J Appl Physiol 2001; 91:1355-1363.
14. Montgomery HE. The genetics of physical fitness. Br J Sports Med 1999; 33 :375.
15. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS. Molecular basis of human hypertension role of angiotensinogen. Cell 1992; 71 :169-180.
16. Corvol P, Jeunemaitre X. Molecular genetics of human hypertension: role of angiotensinogen. Endocr Rev 1997; 18:662-677.
17. Karjalainen J, Kujala UM, Stolt A, Mantysaari M, Vitasalo M, Kainulainen K, et al. Angiotensinogen gene M235 T polymorphism hypertrophy in endurance athletes. J Am Coll Cardiol 1999; 34:494-499.
18. Diet F, Graf C, Mahnke N, Wassmer G, Predel HG, Palma-Hohmann I, et al. ACE and angiotensinogen gene genotypes and left ventricular mass in athletes. Eur J Clin Invest 2001; 31:836-842.
19. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting the anaerobic threshold by gas exchange. J Appl Physiol 1986; 60:2020-2027.
20. Skinner JS, McLellan TH. The transition from aerobic to anaerobic metabolism. Res Q Exerc Sport 1980; 51:234-248.
21. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiography measurements. Circulation 1978; 58:1072-1083.
22. Pereira AC, Mota GFA, Cunha RS, Herbenhoff FL, Mill JG, Krieger JE. Angiotensinogen 235T allele dosage is associated with blood pressure phenotypes. Hypertension 2003; 41:25-30.
23. Evangelista FS, Krieger JE. Small gene effect and exercise training-induced cardiac hypertrophy in mice: an ACE gene dosage study. Physiol Genomics 2006; 27:231-236.
24. Iwai N, Ohmochi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensinogen-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90:2622-2628.
25. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330:1634-1638.
26. Nagashima J, Musha H, Takada H, Awaya T, Oba H, Mori N, et al. Influence of angiotensin-converting enzyme gene polymorphism on development of athlete's heart. Clin Cardiol 2000; 23:621-624.
27. Fagard RH. Impact of different sports and training on cardiac structure and function. Cardiol Clin 1997; 15:397-411.
28. Barbier J, Lebiller E, Ville N, Rannou-Bekono F, Carré F. Relationships between sports-specific of athlete's heart and maximal oxigen uptake. Eur J Cardiovasc Prev Rehabil 2006; 13:115-121.
29. DeMaria AN, Neumann A, Lee G, Fowler W, Mason DT. Alterations in ventricular mass and performance induced by exercise training in man evaluated by echocardiography. Circulation 1978; 57:237-244.
30. Pluim BM, Zwinderman AH, van der Laarse A, van der Wall EE. The athlete's heart: a meta-analysis of cardiac structure and function. Circulation 1999; 100:336-344.
31. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991; 324:295-301.
32. Taylor RR, Mamotte CDS, Fallon K, Bockxmeer FM. Elite's athletes and the gene for angiotensin-converting enzyme. J Appl Physiol 1999; 87 :1035-1037.
33. Defoor J, Vanhees L, Martens K, Matthijs G, Van Vlerken A, Zielinska D, et al. The CAREGENE study: ACE gene I/D polymorphism and effect of physical training on aerobic power in coronary artery disease. Heart 2006; 92 :527-528.